Germany· DE-A57-39a19f8a7cddaa05

Bronchi Plantago

A medicinal product, registered in Germany by Wala Heilmittel Gmbh.

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedBronchi PlantagoATC—REGISTER NO.DE-A57-39a19f8a7cddaa…PACKS LISTED0CHECKEDSeptember 30, 2026

The record

At a glance

EMA Article 57 (European Union)
Manufacturer
Wala Heilmittel Gmbh
Country
Germany (DE)
ATC code
—
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fc593394-7e2e-441c-8c4c-2508609a0958
GET /v1/drugs/fc593394-7e2e-441c-8c4c-2508609a0958?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Subcutaneous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Bronchi Bovis Gl Dil. D16 (Hab, Vs. 41b), Bryonia Cretica Ferm 33b Dil. D7, Eupatorium Cannabinum Ex Herba Ferm 33c Dil. D7 (Hab, Vs. 33c), Larynx Bovis Gl Dil. D16 (Hab, Vs. 41b), Tunica Mucosa Nasi Bovis Gl Dil. D13 (Hab, Vs. 41a), Plantago Lanceolata E Foliis Ferm 34c Dil. D5 (Hab, Vs. 34c), Pyrit Dil. D14 Aquos.",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about Bronchi.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.